Beth Hecht - Chief Legal Officer and Corporate Secretary at Xeris Biopharma Holdings, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Legal Officer and Corporate Secretary
Stock Symbol
XERS on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Beth Hecht - trading volume in the past year for Xeris Biopharma Holdings, Inc.

Holdings reported by Beth Hecht for Xeris Biopharma Holdings, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1.34M $9.89M $7.40 Nov 11, 2025 Direct
Stock Appreciation Right 300K Jan 31, 2025 Direct Common Stock

Transactions reported by Beth Hecht for Xeris Biopharma Holdings, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.